Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-17-001429

Director bought 2,000 shares at $3.31 ($6,620)

From the SEC's structured data for this filing

Trades in this filing

Allen Stephen R. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-25 Purchase : show line 1 in the form +2,000 $3.31 $6,620 7,000 D
Open-market purchases · 2,000 sh · avg $3.31 · $6,620
Loading xslF345X03/form4-08282017_050826.xml…